Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
Price:
57.47
USD
-6.78%
Market Closed
Market Cap:
$8.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR
|
US |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
D
|
Duke Energy Corp
XMUN:D2MN
|
US |
|
C
|
Canadian Natural Resources Ltd
F:CRC
|
CA |
|
D
|
Duke Energy Corp
DUS:D2MN
|
US |
|
Equinor ASA
OTC:STOHF
|
NO |
|
Equinor ASA
OSE:EQNR
|
NO |
Wall St Price Targets
ARWR Price Forecast
Based on 17 analysts
Based on 17 analysts
+89% Upside
from
$57.47
today
Arrowhead Pharmaceuticals Inc (ARWR)’s 12-month stock price forecast through November 2027 has a consensus target of $108.63, implying 89% upside. The forecast is based on price targets from 17 Wall Street analysts.
ARWR Analyst Rating
Based on 15 analysts
Based on 15 analysts
Analysts rate ARWR Strong buy, with 14 of 15 recommending Buy or Strong buy.
Arrowhead Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ARWR's stock price target?
Price Target
108.63
USD
108.63
USD
According to Wall Street analysts, the average 1-year price target for ARWR is 108.63 USD with a low forecast of 74.74 USD and a high forecast of 132.3 USD.
What is the Revenue forecast for Arrowhead Pharmaceuticals Inc?
Projected CAGR
25%
25%
Over the last 13 years, the compound annual growth rate for Revenue has been 100%. The projected CAGR for the next 8 years is 25%.
What is the Operating Income forecast for Arrowhead Pharmaceuticals Inc?
Projected CAGR
50%
50%
The compound annual growth rate for Operating Income over the next 8 years is 50%.
